More on EIKN
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $7.54 |
|
|||
| Open | $7.73 | ||||
| 52 Wk High | $ | ||||
| 52 Wk Low | $ | ||||
| Day High | $7.76 | ||||
| Day Low | $7.19 | ||||
| P/E | N/A | ||||
| EPS | $ | ||||
| Volume | 482,791 | ||||
- H.C. Wainwright Starts Eikon Therapeutics Inc. (EIKN) at Buy
- Eikon Therapeutics files IND for prostate cancer drug EIK1006
- Eikon Therapeutics Submits IND for Novel Androgen Receptor Antagonist EIK1006 in Prostate Cancer
- Form SCHEDULE 13G/A Eikon Therapeutics, Inc. Filed by: FMR LLC
- Form SCHEDULE 13G/A Eikon Therapeutics, Inc. Filed by: Abu Dhabi Investment Authority
- Eikon Therapeutics names new chief scientific officer from Bristol Myers Squibb
- Eikon Therapeutics Appoints Ching-Pin Chang, M.D., Ph.D. as Executive Vice President and Chief Scientific Officer
- Eikon Therapeutics to Participate in Investor Conferences in September 2026
- Eikon Therapeutics (EIKN) Reiterated at Overweight by Cantor Fitzgerald
- Eikon Therapeutics to Participate in KOL Event on Therapeutic Use of PARP Inhibitors in Oncology Hosted by Cantor Fitzgerald
Entities mentioned with EIKN
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- IPO | View Related Stories »
- Earnings | View Related Stories »
- Morgan Stanley | View Related Stories »
- Mizuho | View Related Stories »
- Cantor Fitzgerald | View Related Stories »
- Show More...
